Skip to content

The Therapeutic Effect of Exercise Training on Patients With Dementia and Mild Cognitive Impairment

The Therapeutic Effect of Exercise Training on Old Patients With Dementia and Mild Cognitive Impairment: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03811314
Enrollment
107
Registered
2019-01-22
Start date
2018-04-09
Completion date
2023-12-26
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia

Keywords

Dementia

Brief summary

This study aimed to clarify whether strength training or aerobic training could bring more benefits for patients with dementia, another study is to clarify whether isokinetic or isotonic training could bring more benefits for patients with mild cognitive impairment

Detailed description

Exercise training has been evidenced to bring various of benefits for patients with dementia in past studies. However, whether strength training or aerobic training could bring better benefits has not been confirmed in the past. This study designed to recruit 30 patients with mild dementia in the first year. Every patient will receive strength training using dumbbells, butterfly machine and vertical leg press machine for four weeks. Outcome measures including self care ability, cognitive function, MCP-1, BDNF and IGF-1 levels, and the degree of depression will be recorded before and after the training. In the second year, the investigators also designed to recruit 31 patients with mild dementia. These participants will instead receive aerobic training using stationary bicycle for four weeks. The same outcome measures will be tested as in the first year. The other part of the study recruited 46 patients with mild cognitive impairment, who were randomized into either a four-week isokinetic or isotonic training program. All cases were evaluated by isokinetic peak torque, 36-item Short Form Survey (SF-36), Mini-Mental State Examination (MMSE), Barthel Index, geriatric depression scale (GDS-15), and Timed Up and Go test (TUG test) before and after each kind of training.

Interventions

DEVICEStrength training

Using dumbbells, butterfly machine and vertical leg press machine for strength training, 12 repetition maximum weight for 12 repetition, three times a day, five days a week, for a total of four weeks

DEVICEAerobic training

Using stationary bicycle to perform cardiopulmonary endurance training in 50-70 heart rate reserve for 20 minutes, five days per week, for a total of four weeks

DEVICEIsokinetic trinaing

Using Biodex isokinetic dynanometer and set it in isokinetic mode in 60 degree per second

DEVICEIsotonic training

Using Biodex isokinetic dynanometer and set it in isotonic mode at 60% of the maximal peak torque

Sponsors

Taichung Veterans General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Intervention model description

comparison of therapeutic effect between aerobic and strength training on dementia patient, and comparison of therapeutic effect between isokinetic and isotonic training on patients with mild cognitive impairment

Eligibility

Sex/Gender
ALL
Age
40 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

1. Patients aged above 65 years old 2. Patients with mild dementia with Mini-mental state examination scoring 15 to 26 3. Another arm is patients with mild cognitive impairment and Mini-mental state examination scoring 23 to 27

Exclusion criteria

1. Cardiopulmonary diseases or orthopedical conditions that prohibit the patient from receiving exercise training of our programs 2. Cognitive problems that impede the patient to understand and answer the content of our questionnaires.

Design outcomes

Primary

MeasureTime frameDescription
SF-364 weeksconsists of 36 questions categorized into 8 subdomains, including physical functioning, role limitations due to physical health, pain, general health condition, vitality, social functioning, role limitations due to emotional problems, and emotional well-being.
Montreal Cognitive Assessment4 weeksTo evaluate cognitive function, range from 0-30, higher values represent a better outcome
Geriatric Depression Scale4 weeksTo evaluate patient's depression status, range from 0-15, higher values represent a worse outcome
Timed up and go test4 weeksMeasure the time taken by a patient to stand up from a chair, walk three meters, return, and sit back on the chair
Barthel index4 weeksTo evaluate function of activities of daily living, range from 0-100, higher values represent a better outcome
Mini-mental state examination4 weeksTo evaluate cognitive function, range from 0-30, higher values represent a better outcome

Secondary

MeasureTime frameDescription
Concentration of plasma insulin-like growth factor-1 (IGF-1)4 weeksLower plasma level of IGF-1 is associated with an increased risk of developing Alzheimer's dementia, and higher levels of it may protect against neurodegeneration.
Concentration of plasmamonocyte chemotactic protein-1 (MCP-1)4 weeksThe elevation of MCP-1 concentration usually means the progression of systemic inflammation.
Concentration of serum brain derived neurotrophic factor (BDNF)4 weeksIncreasing BDNF level is related to preventing neurodegeneration.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026